Halothane induces calcium release from human skinned masseter muscle fibers. 1999

H Reyford, and P J Adnet, and B Tavernier, and S Beague, and J Ferri, and R M Krivosic-Horber, and G Haudecoeur
Laboratoire d'Anesthésie et de Médecine d'Urgence, Faculté de Médecine, Lille, France.

BACKGROUND An increase in masseter muscle tone in response to halothane or succinylcholine anesthesia (or both) can be observed in healthy persons. Thus the authors compared the fiber-type halothane and succinylcholine sensitivities in human masseter and vastus lateralis muscles. METHODS Masseter and vastus lateralis muscle segments were obtained from 13 and 9 healthy persons, respectively. After chemical skinning of a single fiber and loading the sarcoplasmic reticulum with Ca++ 0.16 microM solution, halothane (0.5-4 vol% bubbled in the incubating solution), succinylcholine (0.1 microM to 10 mM), or both sensitivities were defined as the concentration inducing more than 10% of the maximum tension obtained by application of 16 microM Ca++ solution. The myofilament response to Ca++ was studied with and without halothane by observing the isometric tension of skinned masseter fibers challenged with increasing concentrations of Ca++. Muscle fiber type was determined by the difference in strontium-induced tension measurements. RESULTS A significant difference in halothane sensitivity was found between type 1 masseter fibers (0.6+/-0.2 vol%; mean +/- SD) versus type 1 (2.7+/-0.6 vol%) and type 2 vastus lateralis muscle (2.5+/-0.4 vol%). Succinylcholine did not induce Ca++ release by the sarcoplasmic reticulum. In the masseter muscle, 0.75 vol% halothane decreased the maximal activated tension by 40% but did not change the Ca++ concentration that yields 50% of the maximal tension. CONCLUSIONS The very low halothane threshold for Ca++ release from the masseter muscle usually could be counteracted by a direct negative inotropic effect on contractile proteins. However, halothane may increase the sensitivity of the sarcoplasmic reticulum Ca++ release to succinylcholine-induced depolarization, leading to an increase in masseter muscle tone.

UI MeSH Term Description Entries
D008297 Male Males
D008406 Masseter Muscle A masticatory muscle whose action is closing the jaws. Masseter Muscles,Muscle, Masseter,Muscles, Masseter
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females
D006221 Halothane A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) 1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013390 Succinylcholine A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for. Succinyldicholine,Suxamethonium,Anectine,Celocurine,Dicholine Succinate,Ditilin,Listenon,Lysthenon,Myorelaxin,Quelicin,Succicuran,Succinylcholine Chloride,Succinylcholine Dibromide,Succinylcholine Dichloride,Succinylcholine Dichloride, Di-H2O,Succinylcholine Diiodide,Succinylcholine Diperchlorate,Succinylcholine Iodide,Suxamethonium Bromide,Suxamethonium Chloride,Bromide, Suxamethonium,Dibromide, Succinylcholine,Dichloride, Succinylcholine,Diiodide, Succinylcholine,Diperchlorate, Succinylcholine,Succinate, Dicholine,Succinylcholine Dichloride, Di H2O
D018485 Muscle Fibers, Skeletal Large, multinucleate single cells, either cylindrical or prismatic in shape, that form the basic unit of SKELETAL MUSCLE. They consist of MYOFIBRILS enclosed within and attached to the SARCOLEMMA. They are derived from the fusion of skeletal myoblasts (MYOBLASTS, SKELETAL) into a syncytium, followed by differentiation. Myocytes, Skeletal,Myotubes,Skeletal Myocytes,Skeletal Muscle Fibers,Fiber, Skeletal Muscle,Fibers, Skeletal Muscle,Muscle Fiber, Skeletal,Myocyte, Skeletal,Myotube,Skeletal Muscle Fiber,Skeletal Myocyte

Related Publications

H Reyford, and P J Adnet, and B Tavernier, and S Beague, and J Ferri, and R M Krivosic-Horber, and G Haudecoeur
January 1990, Biochemical pharmacology,
H Reyford, and P J Adnet, and B Tavernier, and S Beague, and J Ferri, and R M Krivosic-Horber, and G Haudecoeur
November 1990, Anesthesiology,
H Reyford, and P J Adnet, and B Tavernier, and S Beague, and J Ferri, and R M Krivosic-Horber, and G Haudecoeur
April 1982, Canadian journal of physiology and pharmacology,
H Reyford, and P J Adnet, and B Tavernier, and S Beague, and J Ferri, and R M Krivosic-Horber, and G Haudecoeur
October 2018, Journal of applied physiology (Bethesda, Md. : 1985),
H Reyford, and P J Adnet, and B Tavernier, and S Beague, and J Ferri, and R M Krivosic-Horber, and G Haudecoeur
May 1978, Neurology,
H Reyford, and P J Adnet, and B Tavernier, and S Beague, and J Ferri, and R M Krivosic-Horber, and G Haudecoeur
April 1989, Journal of clinical pharmacology,
H Reyford, and P J Adnet, and B Tavernier, and S Beague, and J Ferri, and R M Krivosic-Horber, and G Haudecoeur
June 1985, The Journal of biological chemistry,
H Reyford, and P J Adnet, and B Tavernier, and S Beague, and J Ferri, and R M Krivosic-Horber, and G Haudecoeur
February 1986, The American journal of physiology,
H Reyford, and P J Adnet, and B Tavernier, and S Beague, and J Ferri, and R M Krivosic-Horber, and G Haudecoeur
January 1977, The Journal of general physiology,
H Reyford, and P J Adnet, and B Tavernier, and S Beague, and J Ferri, and R M Krivosic-Horber, and G Haudecoeur
January 1988, Methods in enzymology,
Copied contents to your clipboard!